A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer

Clinical trial NCT04193293 · TERMINATED

Trial details

NCT number: NCT04193293
Sponsor: SecuraBio
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2020-06-01
Primary completion: 2020-12-10
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.